Evidence-based educational guide for patients and caregivers — FDA-approved uses, dosing guidelines, safety warnings, and clinical insights for weight management and obesity treatment for US patients
Medically reviewed by U.S. Licensed Pharmacists | Last updated: July 2026
Phentermine 37.5mg (Phentermine Hydrochloride) is a sympathomimetic amine anorectic (appetite suppressant) that is approved by the U.S. Food and Drug Administration (FDA) for short-term weight management in patients with obesity (BMI ≥ 30 kg/m²) or overweight patients with weight-related health conditions such as hypertension, diabetes, or hyperlipidemia.[1] It is one of the most widely prescribed weight loss medications in the United States, valued for its effectiveness in appetite suppression and metabolic stimulation. Millions of American patients have used Phentermine to support their weight loss journey.
Image Size: 800×600px — Phentermine mechanism of action: norepinephrine release in the hypothalamus
Phentermine works by stimulating the release of norepinephrine in the brain's hypothalamus, which activates the sympathetic nervous system and suppresses appetite. This leads to decreased caloric intake, which facilitates weight loss when combined with a reduced-calorie diet and regular physical activity.[2]
📌 Related Guide: Learn more about Adderall 30mg — a stimulant medication with different clinical applications.
Image Size: 800×600px — Phentermine FDA-approved clinical indications for US patients
Phentermine 37.5mg is indicated for short-term weight management based on FDA approval and clinical guidelines:[1][3]
Note: Results vary per individual. Phentermine should be used as part of a comprehensive weight management plan under medical supervision.
Image Size: 800×600px — Phentermine key information and specifications for US patients
| Drug Class | Sympathomimetic Amine (Anorectic) |
|---|---|
| FDA-Approved Indication | Short-term weight management for obesity (BMI ≥ 30) or overweight with weight-related health conditions |
| Active Ingredient | Phentermine Hydrochloride |
| Onset of Action | 1–2 Hours (Oral Administration) |
| Duration of Effect | Up to 12–14 Hours (Extended Release) |
| Elimination Half-Life | 20–25 Hours (Average) |
| Available Strengths | 15mg, 30mg, 37.5mg |
| Prescription Status | Schedule IV Controlled Substance — Prescription required in the USA |
| Common Brand Names | Adipex-P, Lomaira, Suprenza (orally disintegrating) |
Source: FDA Label for Phentermine (Phentermine Hydrochloride) — see references.
Image Size: 800×600px — Phentermine common and serious side effects
While Phentermine is effective for weight loss, it can cause side effects. Most are dose-related and may diminish with continued therapy. Contact your healthcare provider immediately if you experience severe or persistent side effects.
Image Size: 800×600px — Phentermine drug interactions and contraindications
📌 Related Medication: If you are exploring other weight loss options, read our evidence-based guide on Adderall 30mg for more information on stimulant medications.
📘 Also See: Our comprehensive guide on Ritalin 10mg for ADHD and focus management.
Image Size: 800×600px — Phentermine pharmacology and metabolic pathways
Phentermine is rapidly and completely absorbed following oral administration. Peak plasma concentrations are achieved within 1 to 2 hours. The oral bioavailability of phentermine is approximately 70-80%, making it highly effective when taken by mouth. The drug is moderately lipophilic, allowing it to cross the blood-brain barrier effectively and exert its central nervous system effects.
Once absorbed, phentermine is extensively distributed throughout the body. Approximately 70-80% of the drug is bound to plasma proteins. The volume of distribution is approximately 1-2 L/kg. Its moderate lipophilicity contributes to its rapid onset and prolonged duration of action.
Phentermine is extensively metabolized in the liver via the CYP450 enzyme system, primarily CYP2D6. The major metabolic pathways involve hydroxylation to form various metabolites, which are pharmacologically less active than the parent compound. The CYP2D6 polymorphism can significantly affect the metabolism and efficacy of phentermine.
The elimination half-life of phentermine ranges from 20 to 25 hours, with an average of approximately 22 hours. This long half-life allows for once-daily dosing, making it convenient for patients managing their weight loss program.
Phentermine is primarily excreted in the urine as metabolites. In patients with renal impairment, dose adjustment may be required due to reduced clearance. In patients with hepatic impairment, the metabolism of phentermine may be significantly reduced, necessitating dose reduction or alternative therapy.
📌 Also See: Our guide on Adderall 30mg — a stimulant with different pharmacological properties.
📌 Compare: Ritalin 10mg — a stimulant with a different mechanism of action.
Images are for illustrative purposes only. This medication is available by prescription only.
📋 About This Medication
Phentermine 37.5mg (Phentermine Hydrochloride) is a sympathomimetic amine anorectic used for short-term weight management in patients with obesity and weight-related health conditions. It works by suppressing appetite and stimulating the central nervous system.
This information is for educational purposes only. Always consult your healthcare provider.
📞 Check Availability →This guide is based on evidence from the following authoritative sources. All information is reviewed and updated regularly to reflect the latest clinical guidelines and FDA recommendations.
[1] U.S. Food and Drug Administration — DailyMed: Phentermine (Phentermine Hydrochloride) Label Information. NIH National Library of Medicine.
[2] National Institutes of Health — MedlinePlus. Phentermine: MedlinePlus Drug Information. NIH. Updated 2026.
[3] National Institute of Diabetes and Digestive and Kidney Diseases. Weight Management — NIDDK. NIH. Updated 2026.
[4] Centers for Disease Control and Prevention. Obesity — CDC. Updated 2026.
[5] U.S. Drug Enforcement Administration. Controlled Substance Schedules — Schedule IV. DEA.
[6] National Center for Biotechnology Information. Phentermine — StatPearls. NCBI.
Last reviewed and updated: July 14, 2026. This page is intended for educational purposes and should not replace professional medical advice.